This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Peiyuan Lin: Innovator in Pharmaceutical Formulations
Introduction
Peiyuan Lin is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of histamine releasers. His innovative work has led to the development of methods that enhance the efficacy and safety of pharmaceutical products.
Latest Patents
Peiyuan Lin holds 1 patent for his invention titled "Methods for preparing pharmaceutical formulations." This patent relates to pharmaceutical formulations and methods for preparing formulations of histamine releasers. The invention provides methods for determining the concentration of physiologically acceptable excipients for use in these formulations. Additionally, it offers methods for suppressing pharmaceutically-induced histamine release by administering the formulations to an animal. A kit useful for preparing these pharmaceutical formulations is also included in the patent.
Career Highlights
Peiyuan Lin is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the scientific community but has also had a positive impact on patient care through improved medication formulations.
Collaborations
Peiyuan Lin has collaborated with several esteemed colleagues, including Alison G Floyd and Mir A Hashim. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical science.
Conclusion
Peiyuan Lin's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His work continues to influence the field and enhance the effectiveness of treatments available to patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile